Created at Source Raw Value Validated value
Oct. 26, 2020, 8:29 a.m. oms

Reduction of the lung lesions (They will evaluate by images of the Chest Computed Tomography. In which it is measured through a lung damage assessment scale consisting of: a. No injury (0 points); b. Unilateral lesion with less than three lesions of any type or without expression of lesions in all lung lobes a + b (1 point); c. Unilateral lesion with more than three injuries of any type or involvement of all the lung lobes (2 points); d. Bilateral lung lesions b + b (2 points) b + c (4 points) and c + c (6 points); e. Add one more point if there are lesions in all the lobes between both lungs and f. Add an additional point if there is lung consolidation (bacterial pneumonia or clothing); lymphadenopathy or pleural effusion. The value is between 0 (normal) and 8 (maximum possible involvement). The scale will allow quantifying in percentage the results of the improvement or not of the lung lesions; classifying them as improvement; stabilization or worsening). Measurement time: at baseline and; a month and six months after treatment.

Reduction of the lung lesions (They will evaluate by images of the Chest Computed Tomography. In which it is measured through a lung damage assessment scale consisting of: a. No injury (0 points); b. Unilateral lesion with less than three lesions of any type or without expression of lesions in all lung lobes a + b (1 point); c. Unilateral lesion with more than three injuries of any type or involvement of all the lung lobes (2 points); d. Bilateral lung lesions b + b (2 points) b + c (4 points) and c + c (6 points); e. Add one more point if there are lesions in all the lobes between both lungs and f. Add an additional point if there is lung consolidation (bacterial pneumonia or clothing); lymphadenopathy or pleural effusion. The value is between 0 (normal) and 8 (maximum possible involvement). The scale will allow quantifying in percentage the results of the improvement or not of the lung lesions; classifying them as improvement; stabilization or worsening). Measurement time: at baseline and; a month and six months after treatment.